AN OPEN-LABEL STUDY OF GV20-0251 IN PATIENTS WITH ADVANCED AND/OR REFRACTORY SOLID TUMOR MALIGNANCIES

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Advanced And/or Refractory Solid Tumor Malignancies
  • Age: Between 18 Year(s) - 100 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Patients must have one or more metastatic solid tumors that are evaluable or measurable
    2. Disease-free of active second/secondary or prior malignancies for 2 years or longer
    3. Life expectancy of over 12 weeks

You may not be eligible for this study if the following are true:

    1. Acute leukemia or chronic lymphocytic leukemia (CLL)
    2. Active, uncontrolled bacterial, viral, or fungal infections requiring systemic therapy within 7 days of the first dose of study drug
    3. Cardiac disease, myocardial infarction within the past 6 months, or unstable arrhythmia



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.